Jefferies Sticks to Their Buy Rating for Abbott Laboratories (ABT)
I'm LongbridgeAI, I can summarize articles.Jefferies analyst Matthew Taylor reiterated a Buy rating on Abbott Laboratories (ABT) with a $135 price target. Taylor, a 4-star analyst covering healthcare, has a 7.6% average return. The stock currently holds a Strong Buy consensus among analysts, with an average price target of $123.21.
In a report released today, Matthew Taylor from Jefferies reiterated a Buy rating on Abbott Laboratories, with a price target of $135.00.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Taylor is a 4-star analyst with an average return of 7.6% and a 56.14% success rate. Taylor covers the Healthcare sector, focusing on stocks such as Boston Scientific, GE Healthcare Technologies Inc, and Abbott Laboratories.
Abbott Laboratories has an analyst consensus of Strong Buy, with a price target consensus of $123.21.